Heyuan Biotechnology (Shanghai) Co., Ltd
Initial public offering and listing on the science and Innovation Board
Online roadshow announcement
Sponsor (lead underwriter): Haitong Securities Company Limited(600837)
Co lead underwriter: Guotai Junan Securities Co.Ltd(601211)
The application of Heyuan Biotechnology (Shanghai) Co., Ltd. (hereinafter referred to as “the issuer”, “Heyuan biotechnology” and “the company”) for the initial public offering of RMB ordinary shares and listing on the science and Innovation Board (hereinafter referred to as “this offering”) was examined and approved by the members of the stock listing committee of the science and Innovation Board of Shanghai Stock Exchange on November 4, 2021, It has been approved for registration by China Securities Regulatory Commission (zjxk [2022] No. 61).
This offering is conducted by a combination of directional placement to strategic investors (hereinafter referred to as “strategic placement”), offline inquiry placement to qualified investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding the market value of non restricted A-Shares and non restricted depositary receipts in Shanghai market (hereinafter referred to as “online issuance”).
Haitong Securities Company Limited(600837) (hereinafter referred to as ” Haitong Securities Company Limited(600837) ” or “sponsor (lead underwriter)”) serves as the sponsor (lead underwriter) of this offering, and Guotai Junan Securities Co.Ltd(601211) (hereinafter referred to as ” Guotai Junan Securities Co.Ltd(601211) “) serves as the joint lead underwriter of this offering ( Haitong Securities Company Limited(600837) and Guotai Junan Securities Co.Ltd(601211) collectively referred to as “joint lead underwriters”). The issuer and the co lead underwriters will directly determine the issuance price through the offline preliminary inquiry, and the offline cumulative bidding inquiry will not be conducted. It is proposed to issue 100 million new shares, accounting for 20.28% of the total share capital of the issuer after the issuance.
The initial strategic placement quantity of this issuance is 30 million shares, accounting for 30% of this issuance quantity. The difference between the final strategic placement quantity and the initial strategic placement quantity will be first transferred back to offline issuance. The initial number of shares issued offline is 56 million, accounting for 80% of the number issued after deducting the initial strategic placement, and the initial number of shares issued online is 14 million, accounting for 20% of the number issued after deducting the initial strategic placement. The total quantity of final offline and online issuance is the total quantity of this issuance minus the final strategic placement quantity. The final quantity of online and offline issuance will be determined according to the callback situation.
In order to facilitate investors to understand the relevant information of the issuer and the relevant arrangements of this offering, the issuer and the joint lead underwriter of this offering will hold an online roadshow on this offering. Please pay attention to it.
1. Online roadshow time: 14:00-17:00 on March 10, 2022 (Thursday, t-1);
2. Online roadshow website:
Shanghai Securities roadshow Center: http://roadshow.sseinfo.com.
China Securities Network: http://roadshow.cn.stock.com.
3. Participants: key members of the issuer’s management and relevant personnel of the joint lead underwriters.
The full text of the letter of intent of Heyuan Biotechnology (Shanghai) Co., Ltd. for initial public offering and listing on the science and innovation board and relevant materials can be found on the website of Shanghai Stock Exchange (www.sse. Com. CN) Query.
Please pay attention to it.
Issuer: sponsor (lead underwriter) of Heyuan Biotechnology (Shanghai) Co., Ltd.: Haitong Securities Company Limited(600837) co lead underwriter: Guotai Junan Securities Co.Ltd(601211) March 9, 2022 (there is no text on this page, which is Heyuan Biotechnology (Shanghai)) Joint stock limited company’s initial public offering and listing on the science and Innovation Board (seal page of online roadshow announcement)
Issuer: Heyuan Biotechnology (Shanghai) Co., Ltd. (there is no text on this page, which is the seal page of the online roadshow announcement of Heyuan Biotechnology (Shanghai) Co., Ltd. on initial public offering and listing on the science and Innovation Board)
Sponsor (lead underwriter): Haitong Securities Company Limited(600837) mm / DD / yyyy (there is no text on this page, which is the seal page of the announcement of online roadshow of Heyuan Biotechnology (Shanghai) Co., Ltd. on initial public offering of shares and listing on the science and Innovation Board)
Co lead underwriter: Guotai Junan Securities Co.Ltd(601211) mm / DD / yyyy
